Top Biotechnology companies in Australia by Price to Book Ratio (P/B)

This ranking features the top 10 Biotechnology companies in Australia ranked by Price to Book Ratio (P/B), averaging a Price to Book Ratio (P/B) of 11.23, for January 15, 2025.
#
Name
Price to Book Ratio (P/B)
Reported Date
Stock Price
Change
Price (30 days) Country
1

51.03

Jan. 14, 2025 USD 15.47 4.25%

Australia

2

18.81

Jan. 14, 2025 USD 1.33 6.17%

Australia

3

11.08

Jan. 14, 2025 USD 5.88 0.14%

Australia

4

9.94

Jan. 14, 2025 USD 3.66 3.57%

Australia

5

5.09

Jan. 14, 2025 USD 2.01 -0.68%

Australia

6

4.78

Jan. 14, 2025 USD 173.13 0.11%

Australia

7

3.91

Jan. 14, 2025 USD 1.58 -2.06%

Australia

8

3.59

Jan. 14, 2025 USD 2.14 0.82%

Australia

9

2.69

Jan. 14, 2025 USD 7.32 6.16%

Australia

10

1.38

Jan. 14, 2025 USD 0.62 -2.68%

Australia

Frequently Asked Questions
  • Which Biotechnology company in Australia has the highest Price to Book Ratio (P/B) ?

    The Biotechnology company in Australia with the highest Price to Book Ratio (P/B) is Telix Pharmaceuticals Limited (ASX: TLX.AX) at 51.03.

  • Which Biotechnology company in Australia has the lowest Price to Book Ratio (P/B) ?

    The Biotechnology company in Australia with the lowest Price to Book Ratio (P/B) is Trajan Group Holdings Limited (ASX: TRJ.AX) at 1.38.